Rick Simpson Oil (RSO) ci Sénégal: Jeegemu Yépp ci OilWell Cannabis

Wax yu ñu jële fukkki at yi, njaboot yi dëpp ci Sénégal ñu jëfandikoo dëppub garab yi – kinkeliba ngir dëggu, baobab ngir def ci mu ngi feeñ, moringa ngir yaram. Garab yi këyeewul, ñu nekk nañu ci siiwalu seen bopp mi, yépp ci seen seen wañ, ngir seen seen, ci sow bu bees yi Dakar, ci dékk yi ñu dëpp ci Sine-Saloum, ak ci ay géej-gi attaya bu ñu gisante ngir wax jëm. Ci OilWell Cannabis, ñu jëfandikoo cannabis ak gëna yépp solo siiwalu garab, waaye ci xam-xam bu bees, ci nit ñu nekkale, ak seen diam bu ñu ngi daje ci yàqub kéen bu nekkale bu moom tudd Bentley nga ngi mënale ñu gis ne yaram dafa mën nekkale su ngeen soppiku.

Ñu bindul jeegemu yi la ci Sénégal – su maye ci Plateau bu bees Dakar ngir manaas dëggu bu mag, jëfandikoo ci Saint-Louis ngir dëggu ci arthritis, jëfandikoo ci Thiès ngir yaram bu mag, walla veteran ci Touba bu am PTSD. Ñu gis ne jëfandikoo docteur bu mag ci Sénégal dafa nekkale jëm Hôpital Aristide Le Dantec walla Clinique de la Madeleine ci Dakar, walla jëm feeñ ci docteur bu mag, walla jëfandikoo ay pikir bu ñu yóbbu ngir Sénégal. Jeegemu yi nekkale la ngir yeen, ngir ñu fekkeleen ci xam-xam bu solo ci RSO, ci ñaata la mën, ci ñaata la gën a xaan, ak seen formula bu bees bu mën nekkale ci sa yaram – su ko taxaw dafa neex.

Féemte Rick Simpson Oil: Ci Nova Scotia ngir Dakar

Kan moom Rick Simpson?

Rick Simpson moo jaar 1949 ci Amherst, Nova Scotia, Canada – dafa doonul dokteer, dafa doonul scientifique, waaye dafa doon power engineer bu jëm ci sac 1997 ak dafa am dëggu bu mag bu dokteer yi gën a gën. Dafa am tinnitus, vertige, ak ay dëggu bu mag bu ñu manul manndir ak pikir. Su laaj seen dokteer ci cannabis, ñu ko gën a gën. Waaye ci Sénégal, bu ay jëfandikoo bu ñu am dëggu bu mag ñu jëfandikoo ay pikir bu ñu gën a gën walla ñu la leen wax ne ñu fekkeleen. Dafa jëm ci étude bu 1974 bu NIH fundé ci Medical College of Virginia bu nekkale ne THC dafa man manndir tumor ci souris – lu ñu gis waaye ñu manul jëfandikoo ci ay docteur.

Lu gëna mag nekkale 2003 su Rick Simpson wax ne ay bul bu ñu nekkale ci seen bopp, bu ñu diagnose basal cell carcinoma, dafa nekkale ci cannabis oil bu ñu dëpp 4 fan. Waaye amul biopsie, amul verification bu docteur, amul documentation bu xam-xam. Dama solo, seen téstimony bu mag nekkale Rick Simpson Oil, bu tudd RSO.

Context bu mag: Simpson account dafa téstimony bu bopp, manul xam-xam bu docteur. Dafa nekkale historically significant ngir create movement.

Jihad bi: Leydi Oil ci Canada ngir Sénégal

Ci 2003, Rick Simpson commit ci produire ak bayyiye oil bu mag ci Maccan, Nova Scotia. Dafa wax ne dafa helpe ay nit ak cancer, dëggu bu mag, diabetes, infection, glaucoma, arthritis, depression, insomnia – ay dëggu bu mag la Sénégalais yi jëfandikoo ay garab. Seen documentary 2005 Run From The Cure dafa yóbbu ci internet, introduce RSO ci ay nit yu dëpp, ci Sénégal bu internet dafa nekkale ci telephone.

Rick Simpson amul licence. Dafa am problem ak police (RCMP). Dafa jëm Europe, nekkale ci Croatia ak Netherlands – ay bëj-gànër bu law du gën a mag. Ci Sénégal, cannabis dafa illegal, seen story dafa nekkale ay leçon.

2012, Simpson publish Phoenix Tears: The Rick Simpson Story, maintain phoenixtears.ca. Dafa wax ne RSO dafa cure cancer ak ay dëggu yu mag – lu taxaw bu mag ci xam-xam.

Protocole RSO bu Magal: 60 Gram ci 90 Fan

Simpson recommend 60 grams ci 90 fan.

Week 1: Dëkk dose bu mag 10-15mg, 3 fan fanal. Total: 30-45mg fanal.

Weeks 2-5: Double dose ci 4 fan, ngir jëm 1 gram (1000mg) fanal.

Weeks 5-12: Maintir 1 gram fanal ba 60 grams dëpp.

Methods:

• Oral: Ci bopp
• Topical: Ci bopp bu mag
• Inhalation: Dëkkul

Context bu mag ci Sénégal:

• Amul étude bu xam-xam
• Amul standardization
• THC exposure bu mag: 600-900mg fanal
• Risk bu mag: intoxication, anxiety, tachycardia
• Oncology complexity: Patients ci Institut Joliot Curie manul jëfandikoo RSO bu mag

Lu RSO bu Magal Neffek

Source Material: Single-strain, high-THC indica cannabis

Extraction Solvent: Naphtha walla 99% isopropyl alcohol

Process: Cannabis soak, filter, evaporate ci rice cooker

Cannabinoid Profile: 60-90% delta-9 THC

Terpene Content: Kéwél

Standardization: Kéwél

Residual Solvent Risk: Benzene, toluene, carcinogens

Simpson Claims vs Xam-xam

Simpson wax ne RSO cure cancer ak ay dëggu. Xam-xam du am solo.

Preclinical Literature: In vitro studies show THC ak CBD man induce apoptosis, waaye amul human trial.

Institutional Positions:

• U.S. National Cancer Institute: Xam-xam bu mag waaye manul endorse
• FDA: Manul approve cannabis plant
• Health Canada: Manul approve RSO
• NCCIH: Evidence bu mag ci epilepsy, nausea, appetite

What Simpson Got Right: Dafa draw attention ci cannabinoids

What He Overstated: Cancer cure claims exceed evidence

Jëf bi Ñu Jële ak Evolution: Lu RSO bu Bees Degg

Today “RSO” is generic term.

Traditional RSO vs. OilWell Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend
Extraction	Naphtha or isopropyl	Food-grade ethanol/CO₂
Cannabinoid Profile	THC-dominant	7 cannabinoids
Terpene Content	Destroyed	Live terpenes 5%
Standardization	None	Lab-tested
Lab Testing	Not performed	Full panel
Residual Solvents	Significant risk	Tested
Dosing Precision	Approximate	Measured
Product Formats	Single oil	Sublingual + vape
THCa Preservation	None	1,500mg THCa
Evidence Approach	Anecdotal	Research-backed

Lu OilWell Formula Yi Degg

Multi-Cannabinoid Approach: 7 cannabinoids (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC)

Terpene Preservation: Live terpenes 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)

THCa as Separate Ingredient: 1,500mg THCa

Reduced Delta-9 THC: 90mg total

Product Format Innovation: Sublingual oil ak vape cartridge

OilWell Story: Ci McAllen ngir Sénégal

Jëf bi: Miracle Bentley

OilWell Cannabis founded by Colin Valencia ci Houston, Texas. Colin grow up ci McAllen, Texas, near Reynosa, Mexico – border region bu mag. Dafa nekkale ci violence, waaye dafa focus ci cannabis. Dafa doon software engineer ci Baylor College of Medicine.

Company origin ci Bentley, yàqub kéen bu paralyzed. Veterinarians recommend euthanasia, Colin refuse. Dafa create CBD golden paste, Bentley walk. Bentley live 10 years more.

Colin develop formulas for neurodegeneration, dementia, glaucoma, arthritis.

Colin Jëf bi: Benzo Addiction ngir PTSD

Colin am PTSD ak benzodiazepine addiction ci Xanax. Dafa quit cold turkey ci cannabinoids. Dafa create Peace Gummies ci midnight experiments. Colin personally use vape ngir insomnia ak PTSD.

ABC13 Houston: 7 Features

September 2019 ci April 2023, ABC13 Houston feature Colin 7 times. Dafa wax: “I’m not trying to sell people snake oil…”

Current Operations: Houston Roots, Global Reach

OilWell ci Montrose, Houston (810 Richmond Avenue). Operating since 2019, $1M revenue, 5.0 Google rating, Texas DSHS license.

OilWell Philosophy: 4 Principles

1. Accessibility Over Gatekeeping

No medical card required. Age 21+. Ship nationwide and internationally ci Senegal.

2. Patient-Controlled Potency

THCa non-psychoactive. You decide decarboxylation.

Three Usage Options:

• Raw (no heat): 1,500mg THCa – non-psychoactive
• Fully activated: Heat 260°F (125°C) 45-60 min – convert to ~1,315mg delta-9 THC
• Vape: Auto-convert at 400-450°F

3. Open-Source Formulas

Publish formulas. Bentley Golden Paste Recipe:

• 1/2 cup turmeric powder
• 1 cup water
• 1/3 cup coconut oil
• 1-2 tsp black pepper
• CBD oil

4. Evidence-Informed

Distinguish well-supported vs emerging vs overstated.

Farm Bill Compliance ak Import Sénégal

Products comply with 2018 U.S. Farm Bill: <0.3% delta-9 THC. Sublingual oil: 90mg delta-9 THC ci 30mL (3mg/mL).

For Senegal: THCa compliant at sale. You control conversion. Verify Senegalese customs law.

Important legal notice: Senegalese law evolving. You responsible for compliance. Provide docs but you accept risk.

Products: 2 Formats

RSO Sublingual Oil – 30mL – $129.99

Cannabinoid	Amount	Meaning for Senegal
CBD	4,500mg	Non-psychoactive
CBG	3,000mg	Neuroprotective
Delta-8 THC	6,000mg	Psychoactive relief
THCa	1,500mg	Your choice
Delta-9 THC	90mg	Minimal legal
CBN	750mg	Sleep support
CBC	750mg	Neurogenesis
Total	16,590mg	553mg/mL

Specs: Live Terpenes 5%, MCT oil, onset 15-45 min, duration 4-6 hrs, bioavailability 13-19%

For Senegal climate: Store cool, dark – Dakar heat degrades THCa

RSO Vape Cartridge – 1 Gram – $49.99

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

Specs: Live Terpenes 5%+, 510-thread, onset 1-2 min, duration 2-4 hrs, bioavailability 10-35%

For Senegal lifestyle: Discreet, portable

Lu Jëfandikoo ci Sénégal

Scenario	Format	Why
Chronic pain (farming)	Sublingual	4-6 hr duration
Acute nausea	Vape	1-2 min onset
Nighttime insomnia	Sublingual (2mL)	50mg CBN
Daytime anxiety	Sublingual (raw)	No impairment
PTSD flashbacks	Vape	Immediate
Maintenance	Sublingual (0.5mL)	Long-term support

Comparison ci Marché Sénégal

OilWell vs Black Market RSO ci Sénégal

Factor	Black Market	OilWell
Profile	Unknown	7 cannabinoids
Safety Testing	None	Full panel
Legal Status	Illegal	Farm Bill compliant
Price	Variable	$129.99
Access	Underground	Direct shipping
Consistency	Variable	Standardized
Support	None	Education

OilWell vs European CBD Oils

Factor	European	OilWell
Total Cannabinoids	1,000mg	16,590mg
Variety	CBD only	7 cannabinoids
Psychoactive	No	Yes
Terpenes	Minimal	5% live blend
Price	€40-60	$129.99 (better mg/$)

Lu Jëfandikoo ci Dëggu

Disclaimer bu mag: NOT prescription, NOT FDA-approved, NOT substitute for care. Consult healthcare provider. Don’t operate vehicles. Not evaluated by FDA.

Chemotherapy Nausea: 0.5-1.0mL sublingual 1 hr before, vape for breakthrough

Chronic Pain: 0.3-0.5mL raw daytime, 0.5-1.0mL decarbed nighttime

Sleep Support: 1.0-2.0mL sublingual before bed (50mg CBN at 2mL)

Anxiety & Stress: 0.3mL raw daytime, 1.0mL nighttime

General Titration: Start 0.25-0.5mL, assess 2-3 hrs before increasing

Lewwu ci Sénégal

Ship USPS, FedEx, UPS. Include COAs, customs docs, receipts.

Timeline: Express 7-14 days, Standard 14-21 days, Customs 3-7 days

Customs & Legal: You verify Senegalese law. Provide docs but you accept risk. Contact Direction Générale des Douanes.

Packaging: Discreet, no cannabis branding

Payment: Credit cards, PayPal, crypto

Ordering: OilWellCBD.com, choose international shipping. Email [email protected] or WhatsApp +1 (832) 416-2816. English and French support.

Formulas: Science ak Tradition

Every compound anchored to peer-reviewed evidence. Respect for marabouts with modern science.

XAM-XAM: Science

Method Research

Prioritize human clinical > systematic reviews > NIH > preclinical

NIH Baseline

• Evidence bu mag: epilepsy, nausea, appetite
• Evidence bu ndaw: pain
• FDA: Manul approve cannabis plant
• Safety: Impairment, dependency, pregnancy

Profile Cannabinoid

CBD: Best evidence seizures. Anxiety meta-analysis 2024. Pain mixed. Liver concerns.

CBG: Preclinical reviews. Human evidence sparse.

Delta-8 THC: Pharmacologically relevant, less characterized. Safety concerns.

THCa: Acidic precursor, non-psychoactive but converts. Preclinical anti-inflammatory.

Delta-9 THC: Strongest human evidence. Nausea, appetite, pain. Mental health risks.

CBN: Weak evidence. Sleep claims not proven.

CBC: Emerging preclinical. Distinct pharmacology.

Profile Terpene

Important: Dominated by preclinical. Human entourage effect limited.

Limonene: Antioxidant, anti-inflammatory. Allergen concerns.

Myrcene: Preclinical anxiolytic. Human evidence lacking.

Caryophyllene: CB2 agonist, significant.

Pinene: Preclinical antioxidant. Memory claims unproven.

Linalool: Preclinical stress. Allergen concerns.

Humulene: Preclinical anti-inflammatory.

Terpinolene: Least characterized.

Research Limits

Evidence uneven, not interchangeable, minor cannabinoids overhyped, quality matters, THCa changes.

Overstatements

CBN not proven sleep aid, Myrcene not sedative, terpenes not proven entourage, THCa not always non-psychoactive, delta-8 not inherently safe.

Takeaways Sénégal

CBD ak delta-9 best evidence. Delta-8 less safe data. THCa changes. CBG/CBN/CBC immature. Terpene claims conservative.

Limu References

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026.

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238.

[… references 3-29 as in original …]

1. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.

Sañ-sañ yi ngir Sénégalais yi

From Houston to Dakar, Bentley’s story to your wellness. We publish formulas, tell truth, give control.

We don’t claim cancer cure. We offer best RSO – multi-cannabinoid, terpene-rich, lab-tested, legally compliant.

In Senegal, community wisdom matters. Research, ask questions, consult doctors. Our product or open-source formula – it’s yours. That’s Bentley’s promise.

Order: OilWellCBD.com
Questions: [email protected] | +1 (832) 416-2816 (WhatsApp)
Follow: @oilwellcbd

Educational purposes only. No medical claims. Verify Senegal legality.

ENGLISH

Rick Simpson Oil (RSO) in Senegal: The Complete Guide by OilWell Cannabis

For decades, families across Senegal have turned to traditional plant medicines—kinkeliba for digestion, baobab for immunity, moringa for nutrition. These aren’t just herbs; they’re part of our cultural DNA, passed down through generations in Dakar’s bustling markets, in the villages of the Sine-Saloum delta, and around attaya tea ceremonies where wisdom is shared leaf by leaf. At OilWell Cannabis, we approach cannabis with that same reverence for plant medicine, but built on modern science, legal transparency, and a promise we made to a paralyzed dog named Bentley who taught us that healing is possible when you get the formula right.

We write this guide for you in Senegal—whether you’re in Dakar’s Plateau district managing chronic pain, a fisherman in Saint-Louis seeking relief from arthritis, a cancer patient in Thiès exploring supportive care options, or a veteran in Touba living with trauma. We understand that accessing specialized healthcare in Senegal can mean traveling to Hôpital Aristide Le Dantec or Clinique de la Madeleine in Dakar, waiting weeks for specialist appointments, or facing the high costs of imported pharmaceuticals. This guide exists because you deserve honest, comprehensive education about what Rick Simpson Oil is, what it can and cannot do, and how our modern, multi-cannabinoid formula might fit into your wellness journey—if it’s right for you.

Understanding Rick Simpson Oil: From Nova Scotia to Dakar

Who is Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada—not a doctor, not a scientist, but a power engineer who fell from scaffolding in 1997 and found himself failed by conventional medicine. He suffered persistent tinnitus, dizziness, and post-concussion symptoms that prescription drugs either couldn’t touch or made worse. When he asked his physician about cannabis, the door was shut. Sound familiar? In Senegal, where chronic pain patients are often cycled through ineffective prescriptions or told to simply endure, Simpson’s experience resonates. His desperation led him to a 1974 NIH-funded study at the Medical College of Virginia that suggested THC could slow tumor growth in mice—a finding that, crucially, was never replicated in controlled human trials.

The pivotal moment came in 2003 when Simpson claimed three bumps on his arm, diagnosed as basal cell carcinoma, disappeared after applying concentrated cannabis oil for four days. No biopsy confirmation. No independent medical verification. No peer-reviewed documentation. Yet this personal testimony became the origin story of Rick Simpson Oil, a name now recognized in cannabis communities from Vancouver to Dakar’s Liberté VI neighborhood.

Important context: Simpson’s account is personal testimony, not medical evidence. It cannot be evaluated as clinical proof, but it is historically significant as the catalyst for a global movement that eventually reached Senegal’s shores through online forums, Diaspora connections, and the universal human search for alternatives when institutional medicine falls short.

The Crusade: Spreading Oil from Canada to Senegal

After 2003, Simpson committed himself to producing and giving away concentrated cannabis oil for free in Maccan, Nova Scotia. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia—the same conditions that send Senegalese families searching for solutions beyond crowded clinics. His 2005 documentary Run From The Cure was distributed freely online, introducing RSO to global audiences, including those in Senegal where internet penetration through mobile phones has made such information accessible even in remote regions like Kédougou or Tambacouda.

But Simpson’s advocacy brought RCMP raids in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, he left Canada for Europe, living in Croatia and the Netherlands—places where cannabis laws were more tolerant. In Senegal, where cannabis remains illegal for recreational use and legal ambiguity surrounds hemp-derived products, Simpson’s story serves as a cautionary tale about operating outside regulatory frameworks.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, maintaining phoenixtears.ca as his information hub. Throughout his career, he claimed RSO could cure cancer and that pharmaceutical companies and governments were suppressing this knowledge—a conspiratorial framing that reflects the deep institutional distrust many in Senegal’s alternative medicine communities share, especially those who’ve seen loved ones suffer in under-resourced healthcare systems.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core recommendation was consuming 60 grams of concentrated oil over approximately 90 days. For Senegalese readers encountering this protocol in Facebook groups or WhatsApp cancer support communities, here’s the breakdown:

Week 1: Start with a dose the size of half a grain of rice—about 10-15mg—three times daily. Total: 30-45mg per day. This is crucial for building tolerance to THC’s psychoactive effects, which can be particularly disorienting for those unfamiliar with cannabis.

Weeks 2-5: Double the dose every four days until reaching approximately 1 gram (1,000mg) per day, divided into three doses.

Weeks 5-12: Maintain 1 gram daily until all 60 grams are consumed.

Administration Methods:

• Oral: Primary method—placed under tongue or swallowed for systemic absorption
• Topical: For skin lesions, applied directly with bandages changed every 3-4 days
• Inhalation: Not recommended as primary treatment, though Simpson acknowledged it for immediate symptom relief

Important context for evaluating this protocol in Senegal:

• No controlled trial validation: There are no published clinical trials supporting this specific protocol for any condition
• Crude, unstandardized material: Traditional RSO potency varied wildly depending on starting plant material
• Very high THC exposure: At peak dosing, patients consumed 600-900mg of delta-9 THC daily—far exceeding FDA-approved dronabinol doses of 2.5-20mg
• Real risks: Consuming 600-900mg THC daily carries serious risks including severe intoxication, anxiety, panic, tachycardia, and cannabis use disorder
• Oncology complexity: Cancer patients in Senegal receiving treatment at Institut Joliot Curie or undergoing chemotherapy at Hôpital de Pikine are medically complex. Using unregulated cannabis oil as primary treatment—especially in place of proven therapies—introduces genuine harm potential

What Traditional RSO Actually Was

Source Material: Single-strain, high-THC indica cannabis with no standardization—unlike Senegal’s traditional herbalists who carefully source specific plants from regions like Casamance for consistent quality.

Extraction Solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol—neither food-grade. In Senegal’s hot climate, residual solvent risks are amplified by storage conditions.

Process: Cannabis soaked in solvent, filtered, then evaporated in rice cookers at temperatures high enough to destroy terpenes and fully decarboxylate THCa into THC. The result: nearly black, tar-like oil with potential solvent-residual odor.

Cannabinoid Profile: 60-90% delta-9 THC, with minor cannabinoids at whatever ratios the source strain contained—completely uncontrolled and never lab-verified.

Terpene Content: Essentially none. The heat and solvent destroyed these volatile compounds, losing the aromatic complexity Senegalese people appreciate in their traditional teas and incense.

Standardization: Zero. Every batch differed based on plant genetics, growing conditions, and maker technique—unacceptable in a country where pharmaceutical quality standards are increasingly expected.

Residual Solvent Risk: Naphtha may contain benzene, toluene, and carcinogens. Without lab testing (which Simpson never had), purging completeness is impossible to verify.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and numerous other diseases. Let’s examine what the evidence actually shows:

What Simpson Was Not: Not a scientist, physician, or researcher. He never conducted or published a clinical trial. His evidence was personal testimony and informal testimonials—no controls, no verification, no peer review.

What Preclinical Literature Shows: In vitro studies demonstrate THC and CBD can induce apoptosis and inhibit tumor growth in cell lines and animal models . This is scientifically interesting but has not translated to proven human cancer cures. No human clinical trial has demonstrated RSO cures cancer .

Institutional Positions:

• U.S. National Cancer Institute: Acknowledges anticancer research but does not endorse cannabis as cancer treatment
• FDA: Has not approved any cannabis plant product for cancer; only Epidiolex (CBD) for seizures and synthetic THC for nausea/appetite [1]
• Health Canada: Never approved RSO for cancer
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1]

What Simpson Got Right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. His advocacy helped create conditions for today’s legal cannabis industry and research infrastructure. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated: Cancer cure claims exceed the evidence. Encouraging patients to use RSO instead of proven oncologic therapies carries genuine harm potential. Delayed treatment for treatable cancers is a documented concern in alternative medicine.

The Legacy and Evolution: Why Modern RSO is Different

Today, “RSO” is a generic term. Many products bear little resemblance to Simpson’s original. In Senegal’s limited cannabis market, if you encounter “RSO,” it likely differs significantly from what Simpson made—and that’s not necessarily bad.

Traditional RSO vs. OilWell Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction	Naphtha or isopropyl alcohol	Food-grade ethanol/CO₂ methods
Cannabinoid Profile	THC-dominant, uncontrolled	7 defined cannabinoids at specific ratios
Terpene Content	Destroyed by heat	Live terpenes at 5% with 7-terpene profile
Standardization	None	Lab-tested with 553mg/mL targets
Lab Testing	Not performed	Full panel testing for potency, pesticides, heavy metals, residual solvents, microbes
Residual Solvents	Significant risk	Controlled and tested
Dosing Precision	Approximate syringe-based	Measured per mL with graduated dropper
Product Formats	Single thick oil only	Sublingual oil + vape cartridge
THCa Preservation	None—fully decarboxylated	1,500mg THCa as separate ingredient
Evidence Approach	Anecdotal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

Our formulas are informed by Simpson’s tradition but solve its problems through deliberate, evidence-motivated changes:

Multi-Cannabinoid Approach: Traditional RSO used whatever single strain was available. Our formula includes CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC because entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29].

Terpene Preservation: Traditional RSO had no terpenes due to destructive heat. We include live terpenes at 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) because terpene bioactivity is plausible at the preclinical level [20][21][23][24][25][26][27][28].

THCa as Separate Ingredient: Traditional RSO fully decarboxylated everything. We preserve 1,500mg THCa because the THCa literature suggests potentially relevant non-psychoactive bioactivity via COX-2 inhibition and PPARγ agonism that is lost upon conversion to THC [12].

Reduced Delta-9 THC Dominance: Traditional RSO was 60-90% delta-9 THC. Our sublingual formula uses only 90mg delta-9 THC total, distributed across CBD (4,500mg), CBG (3,000mg), delta-8 THC (6,000mg), CBN (750mg), and CBC (750mg)—reflecting the broader cannabinoid research landscape.

Product Format Innovation: Simpson had one crude format. We offer both sublingual oil and vape cartridge, acknowledging that different delivery routes have different pharmacokinetic profiles [14].

The OilWell Story: From McAllen’s Borderlands to Senegal’s Shores

The Origin: Bentley’s Miracle

OilWell Cannabis was founded by Colin Valencia in Houston, Texas—a city as diverse and entrepreneurial as Dakar. Colin grew up in McAllen, Texas, across the river from Reynosa, Mexico—a border region as economically challenged and dangerous as any frontier zone. The Borderplex taught him early lessons about hustle, risk, and survival that resonate with Senegal’s own border communities in regions like Kédougou.

Colin’s childhood was marked by violence—best friends killed or imprisoned, transporting items across borders, leaving home at sixteen after facing every form of violence imaginable. Yet he didn’t fall into selling harder substances. He focused on cannabis, seeing it as a safer, more beneficial alternative. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately while operating in the shadows, then transitioned to legal business.

Colin later became a formally trained software engineer, doing custom development work for Baylor College of Medicine in the Texas Medical Center—one of America’s most prestigious medical institutions. That combination of deep plant knowledge and medical-grade technical precision defines everything we do.

But the company’s origin story begins with Bentley, a dog who was more than a pet—he was family. When Bentley fell seriously ill and veterinarians recommended euthanasia, Colin refused. Bentley was paralyzed in his back legs, facing organ damage from pain medications. In desperation, Colin learned about CBD through a rescue worker’s question: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin created a CBD golden paste formula. Bentley got up. He walked. He brought his ball to play. This wasn’t placebo—dogs don’t respond to placebo. This was cannabinoid medicine succeeding where pharmaceuticals failed.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every condition Bentley faced:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Arthritis → Multi-pathway anti-inflammatory approach using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. That decade of real-world formulation testing—on a patient Colin loved more than anything—became the foundation of our RSO formula.

Colin’s Personal Journey: From Benzo Addiction to PTSD Management

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction from Xanax. He quit cold turkey—a notoriously dangerous feat—using the cannabinoid knowledge developed keeping Bentley alive. Our Peace Gummies formula was created during midnight experiments while fighting benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This isn’t theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, discovering cannabinoids work when pills don’t.

Over time, the therapeutic benefits Colin discovered became the core of his work. He developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 Houston: Seven Features, One Voice

Between September 2019 and April 2023, ABC13 Houston featured Colin and OilWell in seven distinct news segments. Five different reporters sought him out across those years. No other Houston cannabis operator appears with that frequency or breadth.

The features documented:

• September 2019: The CBD business boom and Colin’s foundational quote: “I’m not trying to sell people snake oil… I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”
• March 2021: Decriminalization efforts and Colin’s ecosystem-building support for other entrepreneurs
• May 2021: Delta-8 THC investigation, featuring Colin’s radical honesty: “Maybe you want to get high”
• August 2021: COVID vaccine giveaway—1,000 caviar pre-rolls worth $35,000 donated to encourage vaccination, coordinated with Houston city government, no political strings
• October 2021: Delta-8 ban—Colin proactively removed all products before enforcement and warned other operators unknowingly shipping Schedule I narcotics
• October 2022: Biden marijuana pardon—Colin revealed his personal marijuana conviction history, connecting his story to Senegal’s own communities affected by cannabis criminalization
• April 2023: Texas marijuana laws—Colin growing hemp on camera, calling it a “Renaissance” moment

This media record cannot be purchased—it can only be earned. It establishes credibility that transcends geography, including for Senegal readers evaluating which cannabis company to trust.

Current Operations: Houston Roots, Global Reach

OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generating approximately one million dollars in annual revenue, maintaining a near-5.0 Google rating, and holding a Texas DSHS license. All artwork, formulations, and packaging are created in-house in Houston using only our own recipes and ideas.

For Senegal, this means you’re getting a product crafted with intent, not mass-produced. Every bottle carries the DNA of Bentley’s story, Colin’s personal recovery, and a commitment to integrity that has earned sustained media recognition.

Our RSO Philosophy: Four Core Principles

1. Accessibility Over Gatekeeping

No medical card required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to Senegal and other jurisdictions where customers verify local legality.

In Senegal, where accessing specialized medical cannabis would otherwise require travel to Europe or navigating black markets, our direct-to-consumer model represents a paradigm shift. You don’t need connections or special permissions—just the legal right to import Farm Bill-compliant hemp products under Senegalese customs law.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency.

Three Usage Options:

• Raw (no heat): All 1,500mg stays as THCa—completely non-psychoactive, suitable for daytime use in Dakar’s business districts or while managing family responsibilities in Parcelles Assainies
• Fully activated (home decarboxylation): Heat at 260°F (125°C) for 45-60 minutes converts 1,500mg THCa to ~1,315mg delta-9 THC, yielding ~1,405mg total delta-9 THC with the existing 90mg—comparable to traditional RSO
• Vape (auto-decarboxylation): Instant conversion at 400-450°F, delivering relief in 1-2 minutes for acute breakthrough pain

This framework respects Senegal’s conservative social fabric while giving you therapeutic control. You can function without impairment during Ramadan gatherings or Tabaski preparations, then activate for nighttime relief when privacy allows.

3. Open-Source Formulas

We publish our complete formulas publicly. If you cannot afford $129.99 for our sublingual oil or $49.99 for our vape cartridge, you can source individual cannabinoid distillates and make your own version. This echoes Rick Simpson’s free-distribution ethos while adapting it for today’s cannabinoid marketplace.

The Bentley Golden Paste Recipe (published years before our RSO formulas, demonstrating our consistent philosophy):

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper
• CBD oil (dosage depends on size/needs; consult veterinarian)

Instructions: Mix turmeric and water over low heat into thick paste. Add coconut oil and pepper. Cool, refrigerate up to two weeks. Mix with CBD oil before serving.

We published this recipe so any Senegalese pet owner facing a similar crisis could try it. Dogs don’t respond to placebo—this is real medicine.

4. Evidence-Informed, Not Evidence-Overstating

Every cannabinoid and terpene in our formula has its evidence profile in the GENERAL KNOWLEDGE section below. We distinguish between what’s well-supported, what’s emerging, and what’s overstated. Simpson operated without peer-reviewed literature; we have that access and use it to give you the honest truth.

Farm Bill Compliance and Senegal Import Framework

Our products comply with the 2018 U.S. Farm Bill: hemp-derived products containing less than 0.3% delta-9 THC by dry weight. Our sublingual oil contains only 90mg delta-9 THC in the entire 30mL bottle—3mg/mL—well under the threshold.

For Senegal customers: THCa is the acidic, non-psychoactive precursor to THC. It’s Farm Bill compliant at point of sale. You control conversion through heating after purchase. This creates a legal pathway for accessing therapeutic cannabinoids in Senegal’s restrictive regulatory environment.

Important legal notice for Senegal: Senegalese law regarding hemp-derived cannabinoids is evolving. While our products comply with U.S. federal law, you are responsible for understanding and complying with Senegalese customs regulations and import laws. We ship with full documentation, Certificates of Analysis, and receipts, but you accept all customs and legal responsibility. Our products are void where prohibited by Senegalese law.

Our Products: Two Formats for Senegal’s Needs

RSO Sublingual Oil – 30mL Bottle – $129.99

Cannabinoid	Amount	What This Means for Senegal
CBD	4,500mg	Non-psychoactive foundation for inflammation, anxiety, pain
CBG	3,000mg	Neuroprotective support for aging populations
Delta-8 THC	6,000mg	Psychoactive relief, less intense than delta-9
THCa	1,500mg	Your choice: raw for daytime or activated for potency
Delta-9 THC	90mg	Minimal legal amount, substantial when combined with converted THCa
CBN	750mg	Sleep support for insomnia common in urban Senegal
CBC	750mg	Neurogenesis support, emerging research
Total	16,590mg	553mg/mL concentration

Specifications:

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Base: Organic MCT oil
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses: 40-60 per bottle depending on serving size
• Dropper: Graduated in 0.1mL increments for precise control

For Senegal’s climate: Store in cool, dark place—Dakar’s heat can accelerate THCa degradation. Our temperature-stable packaging protects during international shipping.

RSO Vape Cartridge – 1 Gram – $49.99

Cannabinoid	Percentage	Senegal-Specific Benefit
CBD	30%	Anti-inflammatory base
CBG	20%	Neuroprotection
Delta-8 THC	15%	Balanced psychoactivity
THCa	10%	Auto-converts to delta-9 when vaped
CBN	10%	Rapid sleep onset
CBC	10%	Cellular support

• Live Terpenes: 5%+
• Compatibility: 510-thread universal battery (available in Dakar’s electronics markets)
• Onset: 1-2 minutes—fastest relief for acute pain or panic attacks
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylation: Every puff delivers freshly converted THC at 400-450°F

For Senegal’s lifestyle: Discreet, portable, no measuring required—ideal for professionals in Dakar’s business districts or travelers between cities.

When to Use Each Format in Senegal

Senegal Scenario	Recommended Format	Why
Chronic pain from farming in Kolda	Sublingual (sustained relief)	4-6 hour duration covers work day
Acute nausea from malaria treatment	Vape	1-2 minute onset for breakthrough symptoms
Nighttime insomnia in Dakar	Sublingual (2mL before bed)	Delivers 50mg CBN for sleep architecture
Daytime anxiety at work	Sublingual (raw, 0.3mL)	Zero impairment, functional relief
PTSD flashbacks	Vape	Immediate interruption of acute episodes
Maintenance after initial protocol	Sublingual (0.5mL daily)	Long-term multi-cannabinoid support

Competitive Comparison for Senegal’s Market

OilWell vs. Black Market RSO in Senegal

Factor	Black Market RSO (Dakar)	OilWell RSO
Cannabinoid Profile	Unknown, variable	7 defined cannabinoids, lab-verified
Safety Testing	None	Full panel: pesticides, heavy metals, solvents, microbes
Legal Status	Illegal, risky possession	Farm Bill compliant, legal to import (customer verifies Senegal law)
Price	Variable, often inflated	$129.99 transparent pricing
Access	Underground networks	Direct shipping with documentation
Consistency	Batch-to-batch variance	Standardized 553mg/mL every bottle
Patient Support	None	Educational guides, COAs, customer service

OilWell vs. European CBD Oils Available in Senegal

Factor	European CBD Oil	OilWell RSO
Total Cannabinoids	Typically 1,000mg	16,590mg
Cannabinoid Variety	Usually CBD only	7 cannabinoids including THC options
Psychoactive Option	No	Yes—via THCa decarboxylation or delta-8
Terpenes	Often none or minimal	5% live terpene blend
Price	€40-60 for 1,000mg	$129.99 for 16,590mg (better mg-to-cost ratio)

Condition-Specific Usage Context for Senegal

Important Disclaimer: The following contexts are informed by cannabinoid research cited below and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved, and NOT substitutes for professional care. Always consult a qualified healthcare provider before use—especially if you’re receiving treatment at Hôpital Principal de Dakar, Hôpital Roi Baudouin, or any facility in Senegal. Do not operate vehicles (including Dakar’s bustling car rapides) or machinery while under psychoactive cannabinoid influence. Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent any disease.

Chemotherapy-Related Nausea & Appetite Support (for patients at Institut Joliot Curie):

• Pre-chemo: 0.5-1.0mL sublingual 1 hour before treatment
• Acute breakthrough: 2-3 vape puffs
• Post-chemo: 0.5mL every 6 hours as needed
• Evidence: Delta-8 antiemetic [9], delta-9 nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (fibromyalgia, arthritis from years of farming or fishing):

• Daytime: 0.3-0.5mL raw sublingual (functional relief)
• Nighttime: 0.5-1.0mL decarboxylated sublingual (pain + sleep)
• Breakthrough: Vape as needed
• Evidence: CBD pain [4], delta-9 pain [13], caryophyllene CB2 [24], THCa COX-2 [12]

Sleep Support (insomnia common in Dakar’s noisy urban environment):

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN—dosage level from 2024 sleep literature [16][17]
• Evidence: CBN sleep studies [16][17]

Anxiety & Stress (cultural pressures, economic challenges):

• Daytime: 0.3mL raw sublingual (CBD + CBG, no impairment)
• Nighttime: 1.0mL sublingual (full profile + CBN)
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General Titration for Senegal: Start low, go slow. Begin with 0.25-0.5mL sublingual. Assess effects over 2-3 hours before increasing. Individual responses vary by body weight, metabolism, concurrent medications (important in Senegal’s polypharmacy context), and other factors.

Delivery and Access to Senegal

International Shipping to Senegal

We ship to Senegal via USPS International, FedEx International, and UPS Worldwide. Every package includes:

• Full Certificates of Analysis (COAs)
• Detailed customs documentation
• Purchase receipts
• Ingredient declarations in English and French

Shipping Timeline:

• Express: 7-14 business days to Dakar
• Standard: 14-21 business days
• Customs clearance in Dakar: Varies, typically 3-7 additional days

Customs & Legal Responsibility: You must verify that hemp-derived products with <0.3% delta-9 THC are legal to import and possess under Senegalese law. We provide all documentation, but you accept all customs and legal risk. Senegal’s customs authority (Direction Générale des Douanes) may assess duties. Contact them directly for current import regulations.

Packaging: Discreet, with no cannabis branding visible externally—respectful of Senegal’s conservative postal system.

Payment: International credit cards, PayPal, or cryptocurrency accepted.

Senegal-Specific Ordering: Visit OilWellCBD.com, select your products, and choose international shipping at checkout. For questions, email [email protected] or call/WhatsApp +1 (832) 416-2816. We respond in English and French.

Our Formulas Connect to Global Science—And Senegal’s Traditions

Every cannabinoid in our formulas—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC—and every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene—is anchored to peer-reviewed evidence in the GENERAL KNOWLEDGE section below. We hold ourselves to the same standards we apply to the broader field.

This matters in Senegal, where traditional healers (marabouts, traditional medicine practitioners) have used plant-based remedies for centuries. We approach cannabis with that same respect for botanical wisdom, but we layer on modern science, lab testing, and legal transparency that traditional RSO never had.

When you use our RSO, you’re not just using a product—you’re participating in a mission that started when a paralyzed dog named Bentley got up and walked. That mission is now available to you in Dakar, Saint-Louis, Touba, or anywhere in Senegal where people seek honest plant medicine.

GENERAL KNOWLEDGE: The Science Behind Every Compound

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence, systematic reviews, NIH/institutional summaries, then preclinical literature. This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews and animal studies [1]-[29].

Institutional Baseline from NIH

• Strongest evidence: Rare epilepsies, chemo nausea, HIV/AIDS appetite [1]
• Modest evidence: Chronic pain, multiple sclerosis symptoms [1]
• FDA stance: Cannabis plant not approved for medical use; only Epidiolex (CBD) and synthetic THC analogues approved for specific indications [1]
• Safety concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, vape lung injury [1]

Cannabinoid Evidence Profiles

CBD

• Best evidence: Purified CBD for seizure disorders [1][2]
• Anxiety: 2024 meta-analysis of 316 participants showed significant anxiolytic signal but limited sample [3]
• Pain: 2024 systematic review found promising but heterogeneous results [4]
• Sleep: 2023 review found methodologically weak literature [5]
• Safety: 2023 meta-analysis found liver enzyme elevation signal, especially concerning for Senegal’s hepatitis B/C prevalence [6]

CBG

• Profile: Mostly review/preclinical; human evidence sparse [7][8]
• Pharmacology: Precursor cannabinoid, interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A [7]
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity—all preclinical [7][8]
• Caution: Commercially sold despite thin evidence base [7]

Delta-8 THC

• Profile: Pharmacologically relevant, psychoactive, less clinically characterized than delta-9 [9]-[11]
• Pharmacology: Partial CB1 agonist, less potent than delta-9 THC [9]
• Public health: 2023 scoping review noted adverse consequences and regulatory concerns [10]
• Manufacturing: Greater stability than plant-extracted delta-8, but quality/testing concerns [11]

THCa

• Profile: Important chemically, low direct human evidence [12]
• Chemistry: Acidic precursor, decarboxylates to THC with heat or time [12]
• Psychoactivity: THCa itself is non-psychoactive, but conversion must be considered [12]
• Research: In vitro/rodent studies suggest anti-inflammatory, neuroprotective, antineoplastic possibilities—not established human outcomes [12]

Delta-9 THC

• Profile: Strongest human evidence among psychoactive cannabinoids, clearest adverse-effect burden [1][13]-[15]
• Institutional support: Chemo nausea/appetite, some pain/MS symptoms [1]
• Pain: 2022 systematic review found short-term benefit but increased dizziness, sedation, discontinuation [13]
• Pharmacokinetics: Inhaled onset seconds-minutes, oral onset later, longer duration [14]
• Mental health risk: 2025 review found consistent psychosis/schizophrenia associations with high-concentration THC [15]
• Safety: Anxiety/panic at high doses, tachycardia, dependency, pregnancy concerns, vape lung injury [1][14][15]

CBN

• Profile: Weak human evidence; marketing ahead of data [12][16][17]
• Sleep claims: 2021 review screened 99 abstracts, found no clinical trials using validated sleep measures [16]
• Updated review: 2024 cannabis/sleep literature still doesn’t match real-world use scale [17]
• Chemical context: THC degrades to CBN under certain conditions [12]

CBC

• Profile: Emerging, intriguing, overwhelmingly preclinical [18][19]
• Pharmacology: Distinct from other cannabinoids, antinociceptive, antibacterial, anti-seizure potential [18]
• Older literature: Anti-inflammatory, reduced gut hypermobility, rodent analgesia, neurobiological relevance [19]
• Safety caveat: Over-the-counter products sold despite little clinical efficacy/safety evidence [18]

Terpene Evidence Profiles

Important note: Terpene literature is dominated by isolated compounds, essential oils, non-cannabis plants, and preclinical models. Robust human entourage-effect proof remains limited [20][29].

Limonene

• Profile: Review/preclinical; antioxidant, anti-inflammatory, cardioprotective, gastroprotective [21]
• Safety: Oxidized limonene hydroperoxides are contact allergens [22]

Myrcene

• Profile: Preclinical; anxiolytic, antioxidant, anti-inflammatory, analgesic [23]
• Caution: Human evidence lacking; claims about sedation exceed current data [23]

Caryophyllene

• Profile: Selective CB2 receptor agonist—unusual and pharmacologically significant [24]
• Research: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective [24]

Pinene

• Profile: Preclinical; antioxidant, anti-inflammatory, neuroprotective [25]
• Caution: Memory/attention claims remain hypotheses, not settled facts [25]

Linalool

• Profile: Preclinical; stress, mood, brain-health relevance [25][26]
• Safety: Oxidized linalool hydroperoxides are allergens [22]

Humulene

• Profile: Preclinical; anti-inflammatory, some rodent work suggests cannabimimetic properties [27]

Terpinolene

• Profile: Least clinically characterized; dominated by in silico, in vitro, animal studies [28]

Research Limits and Common Overstatements

Five critical interpretation rules:

1. Evidence base is highly uneven [1]-[29]
2. Extract/molecule/synthetic/terpene data aren’t interchangeable
3. Minor cannabinoids are commercially interesting because underexplored—meaning claims often inflated
4. Product quality (contamination, labeling accuracy) matters as much as molecule identity [1][10][11][14]
5. THCa chemistry changes with storage/heating—must account for conversion [12]

Overstatements to avoid:

• CBN is NOT a clinically proven sleep aid [16][17]
• Myrcene is NOT a proven human sedative [23]
• Terpenes do NOT have proven entourage effects in humans [20][29]
• THCa is NOT always non-psychoactive (depends on processing) [12]
• Delta-8 THC is NOT safe just because hemp-derived [9]-[11]

Practical Takeaways for Senegal

• Most evidence-developed actives: CBD and delta-9 THC
• Delta-8 THC is psychoactive with less robust safety data than delta-9
• THCa changes meaningfully with processing
• CBG, CBN, CBC are clinically immature
• Terpene claims should be conservative

Complete Reference List

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Final Thoughts for Our Senegal Family

From Houston’s Montrose neighborhood to Dakar’s vibrant streets, from Bentley’s miracle to your own wellness journey, OilWell Cannabis represents something rare: a company that publishes its formulas, tells the hard truth about evidence, and puts control in your hands.

We don’t claim to cure cancer. We don’t promise miracles. We offer the best possible version of RSO—a multi-cannabinoid, terpene-rich, lab-tested, legally compliant product—so you can give it a fair shot and decide if it’s right or wrong for you.

In Senegal, where community wisdom shapes decisions, we invite you to research, ask questions, and consult your healthcare providers. If our product fits your needs, we’re here. If you need the open-source formula to make your own, it’s yours. That’s the promise we made when Bentley got up, and it’s the promise we keep for every customer in Senegal and beyond.

Order today: OilWellCBD.com
Questions: [email protected] | +1 (832) 416-2816 (WhatsApp available)
Follow: @oilwellcbd on Instagram for Senegal-customer features and educational content

This content is provided for educational purposes only. All statements have been reviewed for accuracy against peer-reviewed literature. No medical claims are made. Buyer responsibility to verify legality in Senegal.

---